APOE and neoplasm: Gene set enrichment analysis (GSEA) elucidated that the treatment of tumor cells with recombinant ApoE upregulates NF-κB signaling, which in turn augments the expression of CXCL1 and CXCL5 acting as chemoattractants for immune-repressive myeloid cells [57].